Skip to main content
Essex Bio-Technology Limited logo

Essex Bio-Technology Limited — Investor Relations & Filings

Ticker · 1061 HKEX Manufacturing
Filings indexed 849 across all filing types
Latest filing 2024-09-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1061

About Essex Bio-Technology Limited

http://www.essexbio.com

Essex Bio-Technology Limited is a bio-pharmaceutical company specializing in the development, manufacture, and commercialization of genetically engineered therapeutic Fibroblast Growth Factors (FGFs), particularly recombinant bovine basic FGF (rb-bFGF). The company utilizes recombinant DNA technology to produce biologic drugs aimed at the treatment and healing of surface and organ wounds. Its portfolio includes six flagship biologics approved for a wide range of indications across key therapeutic areas: Ophthalmology, Dermatology, and Wound Healing. Leveraging an in-house R&D platform focused on growth factors and antibodies, the company maintains an active pipeline of projects. Its commercial reach extends to over 14,100 hospitals, supported by 46 regional sales offices.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
Regulatory Filings
2024-09-03 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Regulatory Filings
2024-09-02 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Regulatory Filings
2024-09-02 English
INTERIM REPORT 2024
Regulatory Filings
2024-09-02 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2024-08-27 English
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024
Regulatory Filings
2024-08-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.